|
2025
|
Invention
|
Pharmaceutical composition containing pde4 inhibitor compound a. The present invention relates to... |
|
|
Invention
|
Angiotensin ii receptor antagonist and use thereof in treatment of peripherally-induced neuropath... |
|
|
Invention
|
Antibody-drug conjugate containing thiazolo[5,4-b]pyridine structure and use thereof. The present... |
|
|
Invention
|
B7-h3 binding protein. Provided is a B7-H3 binding protein, and in particular a nanobody and a he... |
|
2024
|
Invention
|
Prmt5 inhibitor and preparation method therefor. The present invention relates to the field of me... |
|
|
Invention
|
Receptor inhibitor, pharmaceutical composition comprising same, and use thereof.
The present inv... |
|
|
Invention
|
B7-h3-binding antibody and use thereof. The present application provides an anti-B7-H3 monoclonal... |
|
|
Invention
|
Tetrahydroisoquinoline derivative and use thereof. The present invention provides a tetrahydroiso... |
|
|
Invention
|
Shp2 inhibitor, pharmaceutical composition containing the same and application thereof.
Provided... |
|
|
Invention
|
Proteolysis targeting chimera compound. The present invention provides a targeted degradation chi... |
|
2023
|
Invention
|
Compound based on orydalmine structure and use thereof. The present invention relates to a compou... |
|
|
Invention
|
Method for treating pneumoconiosis. Provided is a method for preventing, relieving, alleviating a... |
|
|
Invention
|
Egfr degradation agent. The present invention relates to a novel compound of general formula (A) ... |
|
2022
|
Invention
|
Nanocrystalline preparation of rock2 inhibitor and preparation method therefor. A nanocrystalline... |
|
|
Invention
|
Shp2 inhibitor, pharmaceutical composition comprising same, and use thereof. Provided is the foll... |
|
|
Invention
|
Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and ... |
|
|
Invention
|
Method for treating viral infections. Provided is a method for preventing and/or treating viral i... |
|
|
Invention
|
Shp2 inhibitor, pharmaceutical composition comprising same, and application thereof. A following ... |
|
|
Invention
|
P2x3 andor p2x2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereo... |
|
|
Invention
|
Receptor inhibitor, pharmaceutical composition comprising same, and use thereof. The present inve... |
|
2021
|
Invention
|
Sos1 inhibitor, pharmaceutical composition comprising same, and use thereof. An SOS1 inhibitor of... |
|
|
Invention
|
Double-stranded rna molecule targeting ckip-1 and use thereof. The present invention relates to t... |
|
|
Invention
|
Salt of rho-associated protein kinase inhibitor, solid form of the salt, preparation method for s... |
|
|
Invention
|
Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation... |
|
|
Invention
|
Sos1 inhibitor, pharmaceutical composition containing same, and use therefor. An SOS1 inhibitor a... |
|
|
Invention
|
Method for treating graft versus host disease caused by hematopoietic stem cell transplantation. ... |
|
|
Invention
|
Pyrazolopyrimidine compound used as atr kinase inhibitor.
Disclosed is a compound of a general f... |
|
|
Invention
|
Pyrazolopyrimidine compound used as atr kinase inhibitor. Disclosed is a compound of a general fo... |
|
|
Invention
|
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparat... |
|
|
Invention
|
2,4,6-tri-substituted pyrimidine compounds as atr kinase inhibitors.
Provided are compounds repr... |
|
2020
|
Invention
|
Compound for inhibiting and inducing degradation of egfr kinase.
Provided is an EGFR kinase inhi... |
|
|
Invention
|
Compound inhibiting and inducing degradation of egfr and alk.
A new compound of general formula ... |
|
|
Invention
|
Method for treating idiopathic pulmonary fibrosis.
A method for preventing, alleviating and/or t... |
|
|
Invention
|
2, 4, 6-tri-substituted pyrimidine compound as atr kinase inhibitor.
Compounds of general formul... |
|
|
Invention
|
P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition containing same, and use there... |
|
|
Invention
|
Method for treating endometriosis-associated pain by using diaminopyrimidine compound.
A method ... |
|
|
Invention
|
Method for treating cough by using diaminopyrimidine compound.
A method for treating, ... |
|
|
Invention
|
Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and app... |
|
|
Invention
|
Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use ... |
|
|
Invention
|
Method for treating fatty liver disease and/or steatohepatitis.
The present invention falls with... |
|
2019
|
Invention
|
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use ther... |
